| | | |

IBM Seeks Patent on Software that Incorporates Human Emotion

IBM Seeks Patent on Software that Incorporates Human Emotion – IPWatchdog.com | Patents & Patent Law:

IBM patents emotions. How does that make your feel? Sad? Mad? Glad?

Well, let’s not get emotional about this.

But it seems that our friends at IBM, the patent King, has a rather cleaver line on patents. IBM is making efforts to emulate the types of things done by the human emotions. Multiple channels, multiple inputs.

One would assume the same illogical and irrational things that make humans so unique and yet so imperfect. Right.

Steve Brachmann does a nice job of tying in other patent technologies related to communications and information processing that are in the same space.

I like the comment: “It looks like more than a full time job for IBM just keeping track of who is potentially infringing their patents.”

True that. But having 10 patents issued per day give IBM a whole lot of leeway if someone comes after IBM.

‘via Blog this’

Similar Posts

  • | | | |

    Even with patents, the past can be prologue

          One might characterize the patent market of the past several years as a herd of elephants fighting over the last leaves on a tree.  This might be somewhat crude to many but a scan of the landscape of Fortune-100 corporations spending millions litigating accusations of infringement or suing for infringement makes a case.  Or, the flooding of the PTAB with requests for IPR (inter partes review procedure) to determine patent validity also…

  • | | | |

    After DNA patent ruling, Congress must encourage genetic research – The Washington Post

    After DNA patent ruling, Congress must encourage genetic research – The Washington Post: Wow, a unanimous ruling! This is a good thing. Firms cannot patent DNA. That’s a discovery, not an invention. It appears however, that they can patent synthetic DNA, so if they invent a new type of….… of seed or… new type of person, Then they can patent it. ‘via Blog this’

  • | |

    The Patent KING: IBM for 28 years

    IBM is again the leader in patents issued. That’s 28 years and running.  IBM had 9,130 patents issued in 2020, compared to the next highest, Samsung with 6,416.  There’s about 15 electronic and manufacturing companies with 2,000 to 3,000 patents issued. Note that all the top 10 are electronics and/or chip makers.  Forbes has a nice article by Roberts about the top 20 patent recipients of 2020.  Apple, the largest company by market cap ($2.1T),…

  • |

    The World is Halving!

     The world is halving,the World is HALVING.…Q: Bitcoin is due to “half”. Explain what half means and how that might impact the price of bitcoin before and after? and … Q: Which bitcoin miners will be most impacted by the halving event this week? (See Answer below.)  ChatGPT or MS Copilot or Gemini …. nice answers… (See below) Summary of answer: Since inception in 2009, bitcoin has been designed to pay-out half the number of…

  • |

    Don’t Confuse Sustainability with CSR | Ivey Business Journal

    Don’t Confuse Sustainability with CSR | Ivey Business Journal: Definition of sustainability — essentially not imposing additional costs on the future — is quite different from Corporate Social Responsibility, which looks at balancing the needs of all current constituents. This is a very cool article that addresses the key issues that differentiate sustainability from CSR. Even though sustainability is overused and frequently missuses, it is a better term to use and a better utopia to aim for. “It is time…

  • | | | |

    Pfizer says U.S. court invalidates Celebrex patent; generics loom — Reuters

    Pfizer — U.S. court invalidates Celebrex patent; generics loom | Reuters: Ouch!:-( Knocking the block of of the buster. Pfizer is taking a big hit with this court ruling against Celebrex patent. Surprisingly, the stock price, not so much so. Almost not even a jitter as it stays around $32 per share. That’s $3B in annual sales with $2B in the US (relevant to the US court ruling, obviously). IF the company repeats its $51B…